Acebutolol
Lercanidipine may increase the hypotensive activities of Acebutolol.
Acemetacin
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Acemetacin.
Aldesleukin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Aldesleukin.
Advertisement
Alfuzosin
Alfuzosin may increase the hypotensive activities of Lercanidipine.
Aliskiren
Lercanidipine may increase the hypotensive activities of Aliskiren.
Alprenolol
Lercanidipine may increase the hypotensive activities of Alprenolol.
Advertisement
Ambrisentan
Lercanidipine may increase the hypotensive activities of Ambrisentan.
Amifostine
Lercanidipine may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Lercanidipine may increase the hypotensive activities of Amifostine.
Advertisement
Amiloride
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Amiloride.
Amiodarone
The serum concentration of Lercanidipine can be increased when it is combined with Amiodarone.
Amlodipine
Amlodipine may increase the hypotensive activities of Lercanidipine.
Amobarbital
The metabolism of Lercanidipine can be increased when combined with Amobarbital.
Amorolfine
The therapeutic efficacy of Amorolfine can be increased when used in combination with Lercanidipine.
Amphetamine
Amphetamine may increase the hypotensive activities of Lercanidipine.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lercanidipine.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Lercanidipine.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Amyl Nitrite.
Anidulafungin
The therapeutic efficacy of Anidulafungin can be increased when used in combination with Lercanidipine.
Apalutamide
The serum concentration of Lercanidipine can be decreased when it is combined with Apalutamide.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Lercanidipine.
Apraclonidine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Apraclonidine.
Aprepitant
The serum concentration of Lercanidipine can be increased when it is combined with Aprepitant.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Lercanidipine.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Lercanidipine.
Artemether
The therapeutic efficacy of Artemether can be increased when used in combination with Lercanidipine.
Atazanavir
The serum concentration of Lercanidipine can be increased when it is combined with Atazanavir.
Atenolol
Atenolol may increase the hypotensive activities of Lercanidipine.
Atomoxetine
The metabolism of Lercanidipine can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Atorvastatin.
Avanafil
Avanafil may increase the antihypertensive activities of Lercanidipine.
Azilsartan
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Lercanidipine.
Barbital
The metabolism of Lercanidipine can be increased when combined with Barbital.
Benazepril
Lercanidipine may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Lercanidipine.
Benzoic Acid
The therapeutic efficacy of Benzoic Acid can be increased when used in combination with Lercanidipine.
Bepridil
Lercanidipine may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the hypotensive activities of Lercanidipine.
Bethanidine
Bethanidine may increase the hypotensive activities of Lercanidipine.
Bifonazole
The therapeutic efficacy of Bifonazole can be increased when used in combination with Lercanidipine.
Bimatoprost
Lercanidipine may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Lercanidipine may increase the hypotensive activities of Bisoprolol.
Boceprevir
The serum concentration of Lercanidipine can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Lercanidipine can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Lercanidipine can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Lercanidipine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Lercanidipine.
Bretylium
Lercanidipine may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Lercanidipine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lercanidipine.
Bumetanide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Bumetanide.
Bunazosin
The risk or severity of hypotension can be increased when Bunazosin is combined with Lercanidipine.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Lercanidipine.
Bupranolol
Lercanidipine may increase the hypotensive activities of Bupranolol.
Butenafine
The therapeutic efficacy of Butenafine can be increased when used in combination with Lercanidipine.
Butoconazole
The therapeutic efficacy of Butoconazole can be increased when used in combination with Lercanidipine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Lercanidipine.
Cafedrine
Lercanidipine may increase the hypotensive activities of Cafedrine.
Calcium Acetate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Acetate.
Calcium Chloride
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Chloride.
Calcium Chloride Anhydrous
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Chloride.
Calcium Citrate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Citrate.
Calcium Glubionate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium glubionate.
Calcium gluceptate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Gluceptate.
Calcium Gluconate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium gluconate.
Calcium Lactate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium lactate.
Canagliflozin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Canagliflozin.
Candesartan
Lercanidipine may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Lercanidipine may increase the hypotensive activities of Candesartan cilexetil.
Captopril
Lercanidipine may increase the hypotensive activities of Captopril.
Carbamazepine
The metabolism of Lercanidipine can be increased when combined with Carbamazepine.
Carteolol
Carteolol may increase the hypotensive activities of Lercanidipine.
Carvedilol
Lercanidipine may increase the hypotensive activities of Carvedilol.
Casein Allergenic Extract
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Casein.
Caspofungin
The therapeutic efficacy of Caspofungin can be increased when used in combination with Lercanidipine.
Celiprolol
Lercanidipine may increase the hypotensive activities of Celiprolol.
Ceritinib
The serum concentration of Lercanidipine can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Lercanidipine.
Chlorothiazide
Lercanidipine may increase the hypotensive activities of Chlorothiazide.
Chloroxine
The therapeutic efficacy of Chloroxine can be increased when used in combination with Lercanidipine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Lercanidipine.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Lercanidipine.
Cicletanine
Lercanidipine may increase the hypotensive activities of Cicletanine.
Ciclopirox
The therapeutic efficacy of Ciclopirox can be increased when used in combination with Lercanidipine.
Cilazapril
Lercanidipine may increase the hypotensive activities of Cilazapril.
Cimetidine
The serum concentration of Lercanidipine can be increased when it is combined with Cimetidine.
Clarithromycin
The serum concentration of Lercanidipine can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Lercanidipine can be decreased when combined with Clemastine.
Clevidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Lercanidipine.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Lercanidipine.
Clonidine
Clonidine may increase the hypotensive activities of Lercanidipine.
Clopidogrel
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lercanidipine.
Clotrimazole
The metabolism of Lercanidipine can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Lercanidipine.
Cobicistat
The serum concentration of Lercanidipine can be increased when it is combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Lercanidipine.
Cordycepin
The therapeutic efficacy of Cordycepin can be increased when used in combination with Lercanidipine.
Crizotinib
The metabolism of Lercanidipine can be decreased when combined with Crizotinib.
Cryptenamine
Lercanidipine may increase the hypotensive activities of Cryptenamine.
Cyclopenthiazide
Lercanidipine may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
The serum concentration of Cyclosporine can be increased when it is combined with Lercanidipine.
Cyclothiazide
Lercanidipine may increase the hypotensive activities of Cyclothiazide.
Dabrafenib
The serum concentration of Lercanidipine can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Dapagliflozin.
Darunavir
The serum concentration of Lercanidipine can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Lercanidipine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Lercanidipine can be increased when it is combined with Dasatinib.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Lercanidipine.
Decanoic Acid
The therapeutic efficacy of Capric acid can be increased when used in combination with Lercanidipine.
Deferasirox
The serum concentration of Lercanidipine can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Lercanidipine can be decreased when combined with Delavirdine.
Deserpidine
Lercanidipine may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Lercanidipine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Dexmedetomidine.
Diazoxide
Diazoxide may increase the hypotensive activities of Lercanidipine.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Diclofenamide.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Lercanidipine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lercanidipine.
Diltiazem
The metabolism of Lercanidipine can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Dipyridamole.
Dorzolamide
Lercanidipine may increase the hypotensive activities of Dorzolamide.
Doxazosin
Doxazosin may increase the hypotensive activities of Lercanidipine.
Doxycycline
The metabolism of Lercanidipine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Lercanidipine can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Lercanidipine can be decreased when combined with Dronedarone.
Duloxetine
Lercanidipine may increase the orthostatic hypotensive activities of Duloxetine.
Econazole
The therapeutic efficacy of Econazole can be increased when used in combination with Lercanidipine.
Econazole Nitrate
The therapeutic efficacy of Econazole can be increased when used in combination with Lercanidipine.
Efavirenz
The serum concentration of Lercanidipine can be decreased when it is combined with Efavirenz.
Efinaconazole
The therapeutic efficacy of Efinaconazole can be increased when used in combination with Lercanidipine.
Empagliflozin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Empagliflozin.
Enalapril
Lercanidipine may increase the hypotensive activities of Enalapril.
Enalaprilat
Lercanidipine may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Lercanidipine may increase the hypotensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Lercanidipine can be decreased when it is combined with Enzalutamide.
Eplerenone
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Eplerenone.
Epoprostenol
Lercanidipine may increase the hypotensive activities of Epoprostenol.
Eprosartan
Lercanidipine may increase the hypotensive activities of Eprosartan.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Lercanidipine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Lercanidipine.
Erythromycin
The metabolism of Lercanidipine can be decreased when combined with Erythromycin.
Esmolol
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Esmolol.
Ethacrynate
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Etacrynic acid.
Felodipine
Lercanidipine may increase the hypotensive activities of Felodipine.
Fenoldopam
Lercanidipine may increase the hypotensive activities of Fenoldopam.
Ferulic Acid
Lercanidipine may increase the hypotensive activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Lercanidipine.
Fluconazole
The metabolism of Lercanidipine can be decreased when combined with Fluconazole.
Flucytosine
The therapeutic efficacy of Flucytosine can be increased when used in combination with Lercanidipine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Lercanidipine.
Fluvoxamine
The metabolism of Lercanidipine can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Lercanidipine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Lercanidipine can be increased when it is combined with Fosaprepitant.
Fosinopril
Fosinopril may increase the hypotensive activities of Lercanidipine.
Fosphenytoin
The metabolism of Lercanidipine can be increased when combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypotensive activities of Lercanidipine.
Furosemide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Furosemide.
Fusidate
The serum concentration of Lercanidipine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Lercanidipine can be increased when it is combined with Fusidic Acid.
Glyphosate
The therapeutic efficacy of Glyphosate can be increased when used in combination with Lercanidipine.
Griseofulvin
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Lercanidipine.
Griseofulvin microsize
The therapeutic efficacy of Griseofulvin can be increased when used in combination with Lercanidipine.
Guanabenz
Lercanidipine may increase the hypotensive activities of Guanabenz.
Guanadrel
Guanadrel may increase the hypotensive activities of Lercanidipine.
Guanethidine
Lercanidipine may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Lercanidipine.
Haloprogin
The therapeutic efficacy of Haloprogin can be increased when used in combination with Lercanidipine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Lercanidipine.
Hexetidine
The therapeutic efficacy of Hexetidine can be increased when used in combination with Lercanidipine.
Hexobarbital
The metabolism of Lercanidipine can be increased when combined with Hexobarbital.
Hydralazine
Hydralazine may increase the hypotensive activities of Lercanidipine.
Hydrochlorothiazide
Lercanidipine may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Lercanidipine may increase the hypotensive activities of Hydroflumethiazide.
Hypoxis hemerocallidea root extract
The serum concentration of Lercanidipine can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Lercanidipine.
Idelalisib
The serum concentration of Lercanidipine can be increased when it is combined with Idelalisib.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Lercanidipine.
Imatinib
The metabolism of Lercanidipine can be decreased when combined with Imatinib.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Lercanidipine.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Lercanidipine.
Indapamide
Lercanidipine may increase the hypotensive activities of Indapamide.
Indinavir
The serum concentration of Lercanidipine can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Lercanidipine can be increased when it is combined with Indinavir.
Indoramin
Indoramin may increase the hypotensive activities of Lercanidipine.
Iproniazid
Iproniazid may increase the hypotensive activities of Lercanidipine.
Irbesartan
Lercanidipine may increase the hypotensive activities of Irbesartan.
Isavuconazole
The serum concentration of Lercanidipine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Lercanidipine can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Lercanidipine.
Isoconazole
The therapeutic efficacy of Isoconazole can be increased when used in combination with Lercanidipine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Lercanidipine.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Isoxsuprine.
Isradipine
The metabolism of Lercanidipine can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Lercanidipine can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Lercanidipine can be increased when it is combined with Ivacaftor.
Ketanserin
Ketanserin may increase the hypotensive activities of Lercanidipine.
Ketoconazole
The serum concentration of Lercanidipine can be increased when it is combined with Ketoconazole.
Labetalol
Lercanidipine may increase the hypotensive activities of Labetalol.
Lacidipine
Lercanidipine may increase the hypotensive activities of Lacidipine.
Latanoprost
Lercanidipine may increase the hypotensive activities of Latanoprost.
Levobunolol
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Levobupivacaine.
Levodopa
Lercanidipine may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Levosimendan.
Lisinopril
Lercanidipine may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Lercanidipine may increase the hypotensive activities of Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Lercanidipine.
Lofexidine
Lercanidipine may increase the hypotensive activities of Lofexidine.
Lopinavir
The serum concentration of Lercanidipine can be increased when it is combined with Lopinavir.
Losartan
Lercanidipine may increase the hypotensive activities of Losartan.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Lercanidipine.
Luliconazole
The serum concentration of Lercanidipine can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Lercanidipine can be increased when combined with Lumacaftor.
Macitentan
Lercanidipine may increase the hypotensive activities of Macitentan.
Magnesium Hydroxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Lercanidipine is combined with Magnesium hydroxide.
Magnesium Oxide
The risk or severity of hypotension and neuromuscular blockade can be increased when Lercanidipine is combined with Magnesium oxide.
Magnesium Salicylate
The risk or severity of hypotension and neuromuscular blockade can be increased when Lercanidipine is combined with Magnesium salicylate.
Magnesium Sulfate
The risk or severity of hypotension and neuromuscular blockade can be increased when Lercanidipine is combined with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The risk or severity of hypotension and neuromuscular blockade can be increased when Lercanidipine is combined with Magnesium sulfate.
Manidipine
Lercanidipine may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Mannitol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Lercanidipine.
Mephobarbital
The metabolism of Lercanidipine can be increased when combined with Methylphenobarbital.
Mepirodipine
Lercanidipine may increase the antihypertensive activities of Barnidipine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Lercanidipine.
Methazolamide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Methazolamide.
Methohexital
The metabolism of Lercanidipine can be increased when combined with Methohexital.
Methyclothiazide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Methyclothiazide.
Methyldopa
Lercanidipine may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Lercanidipine may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Lercanidipine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Lercanidipine.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Lercanidipine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Lercanidipine.
Metipranolol
Lercanidipine may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Lercanidipine.
Metoprolol
The serum concentration of Lercanidipine can be decreased when it is combined with Metoprolol.
Metyrosine
Lercanidipine may increase the hypotensive activities of Metyrosine.
Mibefradil
Lercanidipine may increase the hypotensive activities of Mibefradil.
Micafungin
The therapeutic efficacy of Micafungin can be increased when used in combination with Lercanidipine.
Miconazole
The therapeutic efficacy of Miconazole can be increased when used in combination with Lercanidipine.
Mifepristone
The serum concentration of Lercanidipine can be increased when it is combined with Mifepristone.
Miltefosine
The therapeutic efficacy of Miltefosine can be increased when used in combination with Lercanidipine.
Minaprine
Minaprine may increase the hypotensive activities of Lercanidipine.
Minoxidil
Minoxidil may increase the hypotensive activities of Lercanidipine.
Mitotane
The serum concentration of Lercanidipine can be decreased when it is combined with Mitotane.
Moclobemide
Moclobemide may increase the hypotensive activities of Lercanidipine.
Moexipril
Lercanidipine may increase the hypotensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Lercanidipine.
Morphine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Morphine.
Moxonidine
Moxonidine may increase the hypotensive activities of Lercanidipine.
Nabilone
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nabilone.
Nadolol
Lercanidipine may increase the hypotensive activities of Nadolol.
Nafcillin
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Nafcillin.
Naftifine
The therapeutic efficacy of Naftifine can be increased when used in combination with Lercanidipine.
Natamycin
The therapeutic efficacy of Natamycin can be increased when used in combination with Lercanidipine.
Nebivolol
Lercanidipine may increase the hypotensive activities of Nebivolol.
Nefazodone
The serum concentration of Lercanidipine can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Lercanidipine can be increased when it is combined with Nelfinavir.
Nesiritide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nesiritide.
Netupitant
The serum concentration of Lercanidipine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Lercanidipine can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypotensive activities of Lercanidipine.
Nicardipine
Lercanidipine may increase the hypotensive activities of Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Lercanidipine.
Nicorandil
Nicorandil may increase the hypotensive activities of Lercanidipine.
Nifedipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nifedipine.
Nilotinib
The metabolism of Lercanidipine can be decreased when combined with Nilotinib.
Nilvadipine
Lercanidipine may increase the hypotensive activities of Nilvadipine.
Nimodipine
Nimodipine may increase the hypotensive activities of Lercanidipine.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Lercanidipine.
Nitrendipine
Lercanidipine may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nitric Oxide.
Nitroglycerin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Nitroglycerin.
Nitroprusside
Lercanidipine may increase the hypotensive activities of Nitroprusside.
Nitroxoline
The therapeutic efficacy of Nitroxoline can be increased when used in combination with Lercanidipine.
Nystatin
The therapeutic efficacy of Nystatin can be increased when used in combination with Lercanidipine.
Obinutuzumab
Lercanidipine may increase the hypotensive activities of Obinutuzumab.
Olaparib
The metabolism of Lercanidipine can be decreased when combined with Olaparib.
Olmesartan
Olmesartan may increase the hypotensive activities of Lercanidipine.
Osimertinib
The serum concentration of Lercanidipine can be increased when it is combined with Osimertinib.
Oxiconazole
The therapeutic efficacy of Oxiconazole can be increased when used in combination with Lercanidipine.
Oxprenolol
Lercanidipine may increase the hypotensive activities of Oxprenolol.
Paclitaxel
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Paclitaxel.
Pafuramidine
The therapeutic efficacy of Pafuramidine can be increased when used in combination with Lercanidipine.
Palbociclib
The serum concentration of Lercanidipine can be increased when it is combined with Palbociclib.
Papaverine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Morphine.
Pargyline
Pargyline may increase the hypotensive activities of Lercanidipine.
Penbutolol
Lercanidipine may increase the hypotensive activities of Penbutolol.
Pentamidine
The therapeutic efficacy of Pentamidine can be increased when used in combination with Lercanidipine.
Pentobarbital
The metabolism of Lercanidipine can be increased when combined with Pentobarbital.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Lercanidipine.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Lercanidipine.
Perindopril
Lercanidipine may increase the hypotensive activities of Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Lercanidipine.
Phenobarbital
The metabolism of Lercanidipine can be increased when combined with Phenobarbital.
Phenoxybenzamine
Lercanidipine may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Lercanidipine may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Lercanidipine may increase the hypotensive activities of Phentolamine.
Phenytoin
The metabolism of Lercanidipine can be increased when combined with Phenytoin.
Pinacidil
Pinacidil may increase the hypotensive activities of Lercanidipine.
Pindolol
Lercanidipine may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Pipamperone.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Lercanidipine.
Polythiazide
Lercanidipine may increase the hypotensive activities of Polythiazide.
Posaconazole
The serum concentration of Lercanidipine can be increased when it is combined with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Pramipexole.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Lercanidipine.
Prazosin
Prazosin may increase the hypotensive activities of Lercanidipine.
Primidone
The metabolism of Lercanidipine can be increased when combined with Primidone.
Procarbazine
Procarbazine may increase the hypotensive activities of Lercanidipine.
Propofol
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Propofol.
Propranolol
Lercanidipine may increase the hypotensive activities of Propranolol.
Quetiapine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Quetiapine.
Quinapril
Lercanidipine may increase the hypotensive activities of Quinapril.
Quinine
Quinine may increase the hypotensive activities of Lercanidipine.
Ramipril
Ramipril may increase the hypotensive activities of Lercanidipine.
Ranolazine
The metabolism of Lercanidipine can be decreased when combined with Ranolazine.
Rasagiline
Rasagiline may increase the hypotensive activities of Lercanidipine.
Remifentanil
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Remifentanil.
Rescinnamine
Lercanidipine may increase the hypotensive activities of Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Lercanidipine.
Rifabutin
The metabolism of Lercanidipine can be increased when combined with Rifabutin.
Rifampin
The metabolism of Lercanidipine can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Lercanidipine can be increased when combined with Rifapentine.
Rifaximin
The risk or severity of hypotension can be increased when Rifaximin is combined with Lercanidipine.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Lercanidipine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Lercanidipine.
Riociguat
Lercanidipine may increase the hypotensive activities of Riociguat.
Risperidone
Lercanidipine may increase the hypotensive activities of Risperidone.
Rituximab
Lercanidipine may increase the hypotensive activities of Rituximab.
Ropinirole
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Ropivacaine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Lercanidipine.
Rotigotine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Rotigotine.
Rucaparib
The metabolism of Lercanidipine can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sacubitril.
Salicylic Acid
The therapeutic efficacy of Salicylic acid can be increased when used in combination with Lercanidipine.
Saquinavir
The serum concentration of Lercanidipine can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Lercanidipine can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Sarilumab.
Secobarbital
The metabolism of Lercanidipine can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the hypotensive activities of Lercanidipine.
Selexipag
Lercanidipine may increase the hypotensive activities of Selexipag.
Sertaconazole
The therapeutic efficacy of Sertaconazole can be increased when used in combination with Lercanidipine.
Sevoflurane
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sevoflurane.
Sildenafil
Sildenafil may increase the antihypertensive activities of Lercanidipine.
Silodosin
The risk or severity of hypotension can be increased when Silodosin is combined with Lercanidipine.
Siltuximab
The serum concentration of Lercanidipine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Lercanidipine can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Lercanidipine.
Sirolimus
The therapeutic efficacy of Sirolimus can be increased when used in combination with Lercanidipine.
Sotalol
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sotalol.
Spirapril
Lercanidipine may increase the hypotensive activities of Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Spironolactone.
ST. JOHN'S WORT EXTRACT
The serum concentration of Lercanidipine can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Streptokinase.
Sufentanil
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Sufentanil.
Sulconazole
The therapeutic efficacy of Sulconazole can be increased when used in combination with Lercanidipine.
Sulfisoxazole
The metabolism of Lercanidipine can be decreased when combined with Sulfisoxazole.
Tadalafil
Tadalafil may increase the antihypertensive activities of Lercanidipine.
Talinolol
Lercanidipine may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of hypotension can be increased when Tamsulosin is combined with Lercanidipine.
Tavaborole
The therapeutic efficacy of Tavaborole can be increased when used in combination with Lercanidipine.
Telaprevir
The serum concentration of Lercanidipine can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Lercanidipine can be increased when it is combined with Telithromycin.
Telmisartan
Lercanidipine may increase the hypotensive activities of Telmisartan.
Terazosin
The risk or severity of hypotension can be increased when Terazosin is combined with Lercanidipine.
Terbinafine
The therapeutic efficacy of Terbinafine can be increased when used in combination with Lercanidipine.
Terconazole
The therapeutic efficacy of Terconazole can be increased when used in combination with Lercanidipine.
Terlipressin
Lercanidipine may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Thalidomide.
Theodrenaline
Lercanidipine may increase the hypotensive activities of Theodrenaline.
Thiamylal
The metabolism of Lercanidipine can be increased when combined with Thiamylal.
Thiopental
The metabolism of Lercanidipine can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Lercanidipine can be increased when combined with Thiopental.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Lercanidipine.
Thymol
The therapeutic efficacy of Thymol can be increased when used in combination with Lercanidipine.
Tibolone
Lercanidipine may increase the hypotensive activities of Tibolone.
Ticlopidine
The metabolism of Lercanidipine can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypotensive activities of Lercanidipine.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Lercanidipine.
Tioconazole
The therapeutic efficacy of Tioconazole can be increased when used in combination with Lercanidipine.
Tizanidine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Tizanidine.
Tocilizumab
The serum concentration of Lercanidipine can be decreased when it is combined with Tocilizumab.
Tolazoline
Lercanidipine may increase the hypotensive activities of Tolazoline.
Tolcapone
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Tolcapone.
Tolnaftate
The therapeutic efficacy of Tolnaftate can be increased when used in combination with Lercanidipine.
Toloxatone
Toloxatone may increase the hypotensive activities of Lercanidipine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Lercanidipine.
Torsemide
Torasemide may increase the hypotensive activities of Lercanidipine.
Trandolapril
Trandolapril may increase the hypotensive activities of Lercanidipine.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Lercanidipine.
Travoprost
Travoprost may increase the hypotensive activities of Lercanidipine.
Treprostinil
Treprostinil may increase the hypotensive activities of Lercanidipine.
Tretinoin
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Tretinoin.
Triamterene
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Triamterene.
Tricalcium Phosphate
The therapeutic efficacy of Lercanidipine can be decreased when used in combination with Calcium Phosphate.
Trichlormethiazide
Lercanidipine may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Lercanidipine.
Trimetrexate
The therapeutic efficacy of Trimetrexate can be increased when used in combination with Lercanidipine.
UNOPROSTONE
Lercanidipine may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Lercanidipine.
Valsartan
Valsartan may increase the hypotensive activities of Lercanidipine.
Vardenafil
Vardenafil may increase the antihypertensive activities of Lercanidipine.
Vemurafenib
The serum concentration of Lercanidipine can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Lercanidipine can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Lercanidipine can be decreased when combined with Verapamil.
Vincamine
Lercanidipine may increase the hypotensive activities of Vincamine.
Vinpocetine
Lercanidipine may increase the hypotensive activities of Vinpocetine.
Voriconazole
The serum concentration of Lercanidipine can be increased when it is combined with Voriconazole.
Xylometazoline
Lercanidipine may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Lercanidipine.
Ziprasidone
The metabolism of Lercanidipine can be decreased when combined with Ziprasidone.
Zofenopril
Lercanidipine may increase the hypotensive activities of Zofenopril.
